Bye Bye, Diabetes: 100 Years With This Vaccine, and We’re Finally Learning Its True Capabilities
A decades-old vaccine might have something to offer people with type 1 diabetes!
A research team at Massachusetts General Hospital is about to begin a five-year-long trial to determine whether BCG can be used in the treatment of diabetes. The life-saving vaccine has been used for nearly a century to prevent tuberculosis. However, recently it has demonstrated the it could have the ability to treat type 1 diabetes. Moreover, it might actually be able to reverse it!
The five-year trial will include 150 participants. They will receive two injections of the vaccine within four months of each other. Over the following four years, they will be given an additional BCG injection annually.
So, how does this incredible vaccine show promise for people with type 1 diabetes? In pre-trial studies, BCG was shown to destroy the blood cells that attack the pancreas and prevent it from making insulin. What’s even more amazing is that the vaccine actually increased the number of positive blood cells that repress diabetes.
Wanna learn more?
Check out the video below! Make sure to let us know what you think of this exciting new trial in the comments below!
★How Can I Help?★
Since 2004, the U.S. government has dispersed $150 million towards type 1 and type 2 diabetes-related efforts. However, to rework government budgets, Congress is now looking into transitioning funding from a three-year grant to a single-year renewable program.
Let’s speak up for type 1 diabetes research and keep the momentum going! Sign this petition to tell U.S. Senator Bill Neslon (FL), chair of the Special Committe Continue reading